Abundant heterotopic bone formation following use of rhBMP-2 in the treatment of acetabular bone defects during revision hip arthroplasty
- PMID: 29896546
- PMCID: PMC5994604
- DOI: 10.1016/j.artd.2017.12.004
Abundant heterotopic bone formation following use of rhBMP-2 in the treatment of acetabular bone defects during revision hip arthroplasty
Abstract
Revision hip arthroplasty in the setting of periacetabular bone loss presents a significant challenge, as options for restoring bone loss are limited. Recombinant human bone morphogenetic protein-2 may offer a solution by promoting bone growth to restore bone stock before implant reimplantation. Here we present a case of a patient with a periprosthetic acetabulum fracture, resulting in pelvic discontinuity as the result of significant periacetabular bone loss. Using a staged approach, periacetabular bone stock was nearly entirely reconstituted using recombinant BMPs and allograft, which resulted in stable fixation, but with abundant heterotopic bone formation. Recombinant BMP-2 offers a useful tool for restoring bone stock in complex hip arthroplasty revision cases with periacetabular bone loss; however, caution must be used as overabundant bone growth as heterotopic ossification may result.
Keywords: Bone defects; Revision arthroplasty; rhBMP-2.
Figures





Similar articles
-
Bone morphogenic protein-2 use in revision total hip arthroplasty with acetabular defects.Int Orthop. 2018 Apr;42(4):783-789. doi: 10.1007/s00264-017-3671-3. Epub 2017 Nov 3. Int Orthop. 2018. PMID: 29098380
-
[Oblong acetabular cup, type TC, for revision total hip arthroplasty].Acta Chir Orthop Traumatol Cech. 2012;79(6):506-11. Acta Chir Orthop Traumatol Cech. 2012. PMID: 23286682 Czech.
-
[Osteosynthesis and cup revision in periprosthetic acetabulum fractures using a Kocher-Langenbeck approach].Oper Orthop Traumatol. 2016 Apr;28(2):91-103. doi: 10.1007/s00064-015-0425-5. Epub 2015 Oct 16. Oper Orthop Traumatol. 2016. PMID: 26475262 Clinical Trial. German.
-
Pelvic discontinuity: current solutions.Bone Joint J. 2013 Nov;95-B(11 Suppl A):109-13. doi: 10.1302/0301-620X.95B11.32764. Bone Joint J. 2013. PMID: 24187366 Review.
-
Periprosthetic fractures of the acetabulum.Instr Course Lect. 2004;53:93-8. Instr Course Lect. 2004. PMID: 15116603 Review.
Cited by
-
Bone Morphogenetic Protein-6 Attenuates Type 1 Diabetes Mellitus-Associated Bone Loss.Stem Cells Transl Med. 2019 Jun;8(6):522-534. doi: 10.1002/sctm.18-0150. Epub 2019 Feb 19. Stem Cells Transl Med. 2019. PMID: 30784225 Free PMC article.
-
Icariin controlled release on a silk fibroin/mesoporous bioactive glass nanoparticles scaffold for promoting stem cell osteogenic differentiation.RSC Adv. 2020 Mar 25;10(20):12105-12112. doi: 10.1039/d0ra00637h. eCollection 2020 Mar 19. RSC Adv. 2020. PMID: 35496600 Free PMC article.
-
A pilot study: Nano-hydroxyapatite-PEG/PLA containing low dose rhBMP2 stimulates proliferation and osteogenic differentiation of human bone marrow derived mesenchymal stem cells.JOR Spine. 2023 Jun 1;6(3):e1258. doi: 10.1002/jsp2.1258. eCollection 2023 Sep. JOR Spine. 2023. PMID: 37780828 Free PMC article.
References
-
- Urist M.R. Bone: formation by autoinduction. Science. 1965;150(3698):893. - PubMed
-
- Ebara S., Nakayama K. Mechanism for the action of bone morphogenetic proteins and regulation of their activity. Spine (Phila Pa 1976) 2002;27(16 Suppl 1):S10. - PubMed
-
- ten Dijke P., Fu J., Schaap P., Roelen B.A. Signal transduction of bone morphogenetic proteins in osteoblast differentiation. J Bone Joint Surg Am. 2003;85-A Suppl 3:34. - PubMed
-
- Wozney J.M., Rosen V., Celeste A.J. Novel regulators of bone formation: molecular clones and activities. Science. 1988;242(4885):1528. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources